| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.909 | 0.003 | 0.929 | Caspase 9 stimulant | 0.926 0.002 DBMET00148 0.892 0.003 DBMET00149 0.929 0.002 DBMET00150 | DBMET00150 | |
| 0.838 | 0.004 | 0.838 | Caspase 3 stimulant | 0.838 0.004 DBMET00148 0.821 0.004 DBMET00149 0.788 0.004 DBMET00150 | ||
| 0.838 | 0.011 | 0.889 | Antiinflammatory | 0.839 0.01 DBMET00148 0.798 0.016 DBMET00149 0.889 0.005 DBMET00150 | DBMET00150 | |
| 0.793 | 0.001 | 0.793 | Catenin beta inhibitor | 0.778 0.001 DBMET00148 0.768 0.001 DBMET00149 0.7 0.002 DBMET00150 | ||
| 0.652 | 0.002 | 0.654 | Vanilloid agonist | 0.654 0.002 DBMET00148 0.598 0.003 DBMET00149 0.514 0.003 DBMET00150 | DBMET00148 | |
| 0.61 | 0.004 | 0.83 | Non-steroidal antiinflammatory agent | 0.608 0.004 DBMET00148 0.575 0.005 DBMET00149 0.83 0.003 DBMET00150 | DBMET00150 | |
| 0.509 | 0.002 | 0.587 | Vanilloid 1 agonist | 0.587 0.002 DBMET00148 0.456 0.003 DBMET00149 0.461 0.003 DBMET00150 | DBMET00148 | |
| 0.47 | 0.017 | 0.593 | DNA damaging | 0.503 0.013 DBMET00148 0.504 0.013 DBMET00149 0.593 0.008 DBMET00150 | DBMET00150 | |
| 0.487 | 0.046 | 0.85 | Transcription factor NF kappa B inhibitor | 0.615 0.029 DBMET00148 0.529 0.04 DBMET00149 0.85 0.01 DBMET00150 | DBMET00150 | |
| 0.511 | 0.071 | 0.713 | Apoptosis agonist | 0.566 0.057 DBMET00148 0.556 0.059 DBMET00149 0.713 0.028 DBMET00150 | DBMET00150 | |
| 0.416 | 0.006 | 0.42 | Cyclooxygenase 1 inhibitor | 0.42 0.006 DBMET00148 0.396 0.007 DBMET00149 0.308 0.013 DBMET00150 | DBMET00148 | |
| 0.384 | 0.025 | 0.384 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.361 0.032 DBMET00148 0.187 0.173 DBMET00150 | ||
| 0.365 | 0.01 | 0.365 | Cyclooxygenase inhibitor | 0.357 0.01 DBMET00148 0.341 0.012 DBMET00149 0.293 0.018 DBMET00150 | ||
| 0.361 | 0.014 | 0.402 | Tyrosine 3 hydroxylase inhibitor | 0.402 0.008 DBMET00148 0.384 0.01 DBMET00149 | DBMET00148 | |
| 0.331 | 0.01 | 0.331 | Cyclooxygenase 2 inhibitor | 0.319 0.011 DBMET00148 0.306 0.013 DBMET00149 0.258 0.019 DBMET00150 | ||
| 0.406 | 0.088 | 0.63 | Cyclophilin D inhibitor | 0.408 0.087 DBMET00148 0.327 0.14 DBMET00149 0.63 0.023 DBMET00150 | DBMET00150 | |
| 0.378 | 0.063 | 0.394 | Vasodilator, peripheral | 0.394 0.057 DBMET00148 0.273 0.111 DBMET00149 0.319 0.087 DBMET00150 | DBMET00148 | |
| 0.289 | 0.005 | 0.289 | GABA C receptor antagonist | 0.258 0.006 DBMET00148 0.252 0.006 DBMET00149 | ||
| 0.279 | 0.003 | 0.289 | Arachidonic acid antagonist | 0.289 0.002 DBMET00148 0.28 0.003 DBMET00149 0.226 0.014 DBMET00150 | DBMET00148 | |
| 0.268 | 0.009 | 0.268 | GABA C receptor rho-2 antagonist | 0.256 0.01 DBMET00148 0.249 0.012 DBMET00149 | ||
| 0.257 | 0.004 | 0.257 | GABA C receptor rho-1 antagonist | 0.223 0.005 DBMET00148 0.216 0.006 DBMET00149 | ||
| 0.355 | 0.113 | 0.355 | Calcium channel L-type activator | 0.352 0.116 DBMET00148 0.342 0.123 DBMET00149 | ||
| 0.202 | 0.013 | 0.213 | Antineoplastic alkaloid | 0.207 0.012 DBMET00148 0.213 0.01 DBMET00149 0.122 0.037 DBMET00150 | DBMET00149 | |
| 0.228 | 0.041 | 0.231 | Lipocortins synthesis antagonist | 0.231 0.04 DBMET00148 0.217 0.047 DBMET00149 0.18 0.071 DBMET00150 | DBMET00148 | |
| 0.298 | 0.112 | 0.298 | Toll-Like receptor agonist | 0.294 0.115 DBMET00148 | ||
| 0.193 | 0.007 | 0.208 | Peroxisome proliferator-activated receptor gamma agonist | 0.182 0.008 DBMET00148 0.208 0.006 DBMET00149 0.094 0.031 DBMET00150 | DBMET00149 | |
| 0.305 | 0.121 | 0.352 | Histamine release inhibitor | 0.352 0.099 DBMET00148 0.23 0.172 DBMET00149 0.336 0.106 DBMET00150 | DBMET00148 | |
| 0.296 | 0.112 | 0.296 | Toll-Like receptor 7 agonist | 0.293 0.115 DBMET00148 | ||
| 0.263 | 0.091 | 0.372 | Lipoxygenase inhibitor | 0.372 0.045 DBMET00148 0.316 0.063 DBMET00149 | DBMET00148 | |
| 0.216 | 0.048 | 0.25 | Mcl-1 antagonist | 0.25 0.036 DBMET00148 0.241 0.039 DBMET00149 | DBMET00148 | |
| 0.272 | 0.105 | 0.325 | Sodium/bile acid cotransporter inhibitor | 0.325 0.058 DBMET00148 0.316 0.065 DBMET00149 | DBMET00148 | |
| 0.176 | 0.029 | 0.176 | MAP3K9 inhibitor | 0.172 0.033 DBMET00148 0.166 0.04 DBMET00149 | ||
| 0.155 | 0.009 | 0.166 | Leukotriene synthesis inhibitor | 0.166 0.007 DBMET00148 0.161 0.008 DBMET00149 0.073 0.042 DBMET00150 | DBMET00148 | |
| 0.15 | 0.004 | 0.16 | Nicotinic acid receptor agonist | 0.16 0.004 DBMET00148 0.092 0.005 DBMET00149 | DBMET00148 | |
| 0.253 | 0.124 | 0.497 | Antithrombotic | 0.267 0.113 DBMET00148 0.229 0.145 DBMET00149 0.497 0.029 DBMET00150 | DBMET00150 | |
| 0.201 | 0.073 | 0.207 | Insulin sensitizer | 0.207 0.067 DBMET00148 0.169 0.108 DBMET00149 | DBMET00148 | |
| 0.153 | 0.029 | 0.17 | Photosensitizer | 0.152 0.03 DBMET00148 0.131 0.045 DBMET00149 0.17 0.021 DBMET00150 | DBMET00150 | |
| 0.184 | 0.071 | 0.184 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.162 0.082 DBMET00148 | ||
| 0.288 | 0.178 | 0.288 | 5 Hydroxytryptamine release inhibitor | 0.282 0.186 DBMET00148 0.242 0.24 DBMET00150 | ||
| 0.193 | 0.084 | 0.241 | Neurotrophic factor enhancer | 0.241 0.044 DBMET00148 0.231 0.051 DBMET00149 0.165 0.117 DBMET00150 | DBMET00148 | |
| 0.191 | 0.083 | 0.191 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.175 0.1 DBMET00148 | ||
| 0.236 | 0.135 | 0.405 | Interleukin 2 agonist | 0.262 0.106 DBMET00148 0.269 0.099 DBMET00149 0.405 0.026 DBMET00150 | DBMET00150 | |
| 0.116 | 0.02 | 0.144 | Glycine receptor antagonist | 0.093 0.039 DBMET00148 0.107 0.026 DBMET00149 0.144 0.009 DBMET00150 | DBMET00150 | |
| 0.1 | 0.005 | 0.173 | HCV NS5B polymerase inhibitor | 0.115 0.004 DBMET00148 0.173 0.004 DBMET00149 | DBMET00149 | |
| 0.2 | 0.113 | 0.525 | Antioxidant | 0.32 0.055 DBMET00148 0.283 0.069 DBMET00149 0.525 0.017 DBMET00150 | DBMET00150 | |
| 0.089 | 0.007 | 0.09 | Nicotinic acid receptor 2 agonist | 0.09 0.007 DBMET00148 0.074 0.009 DBMET00149 0.043 0.018 DBMET00150 | DBMET00148 | |
| 0.201 | 0.121 | 0.3 | DNA synthesis inhibitor | 0.213 0.103 DBMET00148 0.215 0.101 DBMET00149 0.3 0.043 DBMET00150 | DBMET00150 | |
| 0.252 | 0.18 | 0.252 | Analgesic | 0.244 0.188 DBMET00148 | ||
| 0.066 | 0.01 | 0.066 | Sphingosine 1-phosphate receptor 1 agonist | 0.05 0.02 DBMET00148 0.042 0.03 DBMET00149 | ||
| 0.108 | 0.057 | 0.155 | 5-Lipoxygenase inhibitor | 0.155 0.036 DBMET00148 0.141 0.041 DBMET00149 | DBMET00148 | |
| 0.185 | 0.135 | 0.185 | 5 Hydroxytryptamine release stimulant | 0.175 0.146 DBMET00148 | ||
| 0.062 | 0.015 | 0.062 | Sphingosine 1-phosphate receptor agonist | 0.043 0.032 DBMET00148 | ||
| 0.056 | 0.011 | 0.056 | RNA-directed RNA polymerase inhibitor | 0.053 0.012 DBMET00148 0.054 0.011 DBMET00149 | ||
| 0.106 | 0.061 | 0.106 | GABA C receptor agonist | 0.095 0.072 DBMET00148 0.095 0.072 DBMET00149 | ||
| 0.079 | 0.035 | 0.079 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.045 DBMET00148 0.074 0.044 DBMET00149 | ||
| 0.069 | 0.027 | 0.069 | Prostaglandin antagonist | |||
| 0.119 | 0.078 | 0.154 | Alpha-N-acetylglucosaminidase inhibitor | 0.154 0.052 DBMET00150 | DBMET00150 | |
| 0.148 | 0.11 | 0.167 | Phospholipase C inhibitor | 0.167 0.077 DBMET00148 0.163 0.083 DBMET00149 | DBMET00148 | |
| 0.038 | 0.009 | 0.038 | Prostaglandin D2 antagonist | 0.024 0.015 DBMET00148 | ||
| 0.033 | 0.012 | 0.033 | Kainate receptor 4 antagonist | 0.023 0.019 DBMET00148 0.026 0.016 DBMET00149 | ||
| 0.038 | 0.017 | 0.042 | Melatonin 2 agonist | 0.042 0.014 DBMET00148 0.029 0.028 DBMET00150 | DBMET00148 | |
| 0.094 | 0.075 | 0.236 | Topoisomerase I inhibitor | 0.148 0.042 DBMET00148 0.123 0.054 DBMET00149 0.236 0.019 DBMET00150 | DBMET00150 | |
| 0.032 | 0.016 | 0.035 | Liver X receptor alpha antagonist | 0.035 0.012 DBMET00148 | DBMET00148 | |
| 0.035 | 0.02 | 0.035 | Peroxisome proliferator-activated receptor delta antagonist | 0.033 0.023 DBMET00148 0.032 0.026 DBMET00149 | ||
| 0.044 | 0.031 | 0.052 | NMDA receptor subunit 3B antagonist | 0.052 0.023 DBMET00148 | DBMET00148 | |
| 0.035 | 0.025 | 0.035 | Retinoid X receptor agonist | |||
| 0.091 | 0.081 | 0.091 | Ferrochelatase inhibitor | |||
| 0.037 | 0.027 | 0.046 | NMDA receptor subunit 3A antagonist | 0.046 0.022 DBMET00148 | DBMET00148 | |
| 0.083 | 0.075 | 0.102 | Alcohol dehydrogenase inhibitor | 0.102 0.051 DBMET00148 | DBMET00148 | |
| 0.077 | 0.069 | 0.089 | NMDA receptor antagonist | 0.089 0.055 DBMET00148 | DBMET00148 | |
| 0.044 | 0.037 | 0.049 | Peroxisome proliferator-activated receptor alpha agonist | 0.049 0.033 DBMET00149 | DBMET00149 | |
| 0.03 | 0.023 | 0.033 | Liver X receptor antagonist | 0.033 0.019 DBMET00148 | DBMET00148 | |
| 0.135 | 0.131 | 0.136 | Anesthetic general | 0.135 0.131 DBMET00148 0.136 0.13 DBMET00149 | DBMET00149 | |
| 0.13 | 0.125 | 0.151 | Interleukin 6 antagonist | 0.132 0.12 DBMET00148 0.151 0.087 DBMET00149 0.13 0.125 DBMET00150 | DBMET00149 | |
| 0.017 | 0.013 | 0.017 | Kainate receptor 3 antagonist | |||
| 0.019 | 0.016 | 0.019 | Kainate receptor 5 antagonist | |||
| 0.03 | 0.028 | 0.033 | Melatonin 1 agonist | 0.033 0.023 DBMET00148 | DBMET00148 | |
| 0.031 | 0.028 | 0.031 | Progesterone antagonist | 0.03 0.029 DBMET00148 | ||
| 0.12 | 0.117 | 0.145 | CC chemokine 6 receptor antagonist | 0.127 0.082 DBMET00149 0.145 0.029 DBMET00150 | DBMET00150 | |
| 0.064 | 0.061 | 0.064 | MDM2 inhibitor | |||
| 0.036 | 0.035 | 0.036 | AMPA 4 receptor antagonist | |||
| 0.027 | 0.033 | 0.029 | Melatonin agonist | 0.029 0.028 DBMET00148 | DBMET00148 | |
| 0.14 | 0.147 | 0.171 | Hypolipemic | 0.165 0.122 DBMET00149 0.171 0.117 DBMET00150 | DBMET00150 | |
| 0.063 | 0.07 | 0.067 | CDC25A inhibitor | 0.067 0.061 DBMET00148 | DBMET00148 | |
| 0.054 | 0.065 | 0.059 | Cyclin B3 inhibitor | 0.059 0.057 DBMET00148 | DBMET00148 | |
| 0.053 | 0.064 | 0.097 | Phosphofructokinase-1 inhibitor | 0.07 0.048 DBMET00149 0.097 0.033 DBMET00150 | DBMET00150 | |
| 0.053 | 0.076 | 0.151 | Phosphodiesterase V inhibitor | 0.151 0.01 DBMET00149 | DBMET00149 | |
| 0.011 | 0.035 | 0.015 | Thyroid hormone alpha agonist | 0.015 0.013 DBMET00149 | DBMET00149 | |
| 0.051 | 0.08 | 0.063 | Sirtuin 1 inhibitor | 0.063 0.055 DBMET00149 | DBMET00149 | |
| 0.129 | 0.158 | 0.144 | Succinate dehydrogenase inhibitor | 0.144 0.124 DBMET00149 | DBMET00149 | |
| 0.141 | 0.17 | 0.163 | Cyclic AMP phosphodiesterase inhibitor | 0.163 0.131 DBMET00148 | DBMET00148 | |
| 0.134 | 0.164 | 0.213 | Platelet antagonist | 0.213 0.092 DBMET00150 | DBMET00150 | |
| 0.05 | 0.082 | 0.152 | Phosphodiesterase 5A inhibitor | 0.152 0.01 DBMET00149 | DBMET00149 | |
| 0.09 | 0.123 | 0.136 | Estrogen antagonist | 0.136 0.031 DBMET00148 0.122 0.051 DBMET00149 | DBMET00148 | |
| 0.101 | 0.134 | 0.221 | Thrombolytic | 0.221 0.043 DBMET00150 | DBMET00150 | |
| 0.084 | 0.122 | 0.152 | Microtubule formation inhibitor | 0.152 0.037 DBMET00150 | DBMET00150 | |
| 0.065 | 0.106 | 0.206 | Phosphodiesterase XI inhibitor | 0.206 0.004 DBMET00149 | DBMET00149 | |
| 0.065 | 0.106 | 0.206 | Phosphodiesterase 11A inhibitor | 0.206 0.004 DBMET00149 | DBMET00149 | |
| 0.103 | 0.147 | 0.137 | Farnesoid X receptor antagonist | 0.137 0.07 DBMET00148 0.135 0.073 DBMET00149 | DBMET00148 | |
| 0.072 | 0.116 | 0.1 | Anabolic | 0.1 0.062 DBMET00148 | DBMET00148 | |
| 0.122 | 0.169 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.119 DBMET00150 | DBMET00150 | |
| 0.045 | 0.096 | 0.072 | Porphobilinogen synthase inhibitor | 0.072 0.054 DBMET00149 | DBMET00149 | |
| 0.109 | 0.161 | 0.147 | Melanin inhibitor | 0.147 0.086 DBMET00148 0.139 0.097 DBMET00150 | DBMET00148 | |
| 0.1 | 0.154 | 0.147 | Insulin secretagoues | 0.147 0.077 DBMET00150 | DBMET00150 | |
| 0.141 | 0.197 | 0.38 | Hypoglycemic | 0.181 0.132 DBMET00148 0.38 0.031 DBMET00150 | DBMET00150 | |
| 0.058 | 0.114 | 0.082 | Estrogen receptor alpha antagonist | 0.082 0.046 DBMET00148 0.072 0.063 DBMET00149 | DBMET00148 | |
| 0.015 | 0.072 | 0.025 | Thyroid hormone agonist | 0.025 0.02 DBMET00148 | DBMET00148 | |
| 0.062 | 0.127 | 0.083 | Triose-phosphate isomerase inhibitor | 0.083 0.071 DBMET00150 | DBMET00150 | |
| 0.079 | 0.145 | 0.167 | Cyclooxygenase 3 inhibitor | 0.167 0.035 DBMET00150 | DBMET00150 | |
| 0.011 | 0.079 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 DBMET00150 | DBMET00150 | |
| 0.065 | 0.136 | 0.12 | Estrogen receptor beta antagonist | 0.12 0.032 DBMET00148 0.109 0.048 DBMET00149 | DBMET00148 | |
| 0.038 | 0.113 | 0.064 | Histidine decarboxylase inhibitor | 0.064 0.058 DBMET00148 | DBMET00148 | |
| 0.025 | 0.105 | 0.089 | Protein 50S ribosomal subunit inhibitor | 0.089 0.016 DBMET00150 | DBMET00150 | |
| 0.072 | 0.16 | 0.108 | DOPA decarboxylase inhibitor | 0.108 0.062 DBMET00148 0.101 0.075 DBMET00149 | DBMET00148 | |
| 0.019 | 0.113 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.029 DBMET00148 | DBMET00148 | |
| 0.041 | 0.139 | 0.064 | Potassium channel large-conductance Ca-activated activator | 0.064 0.053 DBMET00149 | DBMET00149 | |
| 0.035 | 0.136 | 0.072 | Na+ K+ transporting ATPase inhibitor | 0.072 0.058 DBMET00150 | DBMET00150 | |
| 0.012 | 0.113 | 0.039 | Sodium/glucose cotransporter inhibitor | 0.039 0.007 DBMET00150 | DBMET00150 | |
| 0.108 | 0.211 | 0.408 | Free radical scavenger | 0.227 0.079 DBMET00148 0.219 0.084 DBMET00149 0.408 0.027 DBMET00150 | DBMET00150 | |
| 0.028 | 0.134 | 0.14 | Antineoplastic antibiotic | 0.14 0.033 DBMET00150 | DBMET00150 | |
| 0.099 | 0.209 | 0.167 | Aldehyde oxidase inhibitor | 0.167 0.125 DBMET00148 | DBMET00148 | |
| 0.048 | 0.158 | 0.104 | Protein-tyrosine phosphatase 1B inhibitor | 0.104 0.074 DBMET00149 | DBMET00149 | |
| 0.025 | 0.139 | 0.051 | Alpha-mannosidase inhibitor | 0.051 0.041 DBMET00150 | DBMET00150 | |
| 0.024 | 0.143 | 0.277 | Selectin antagonist | 0.277 0.007 DBMET00150 | DBMET00150 | |
| 0.064 | 0.184 | 0.112 | Phosphodiesterase inhibitor | 0.112 0.091 DBMET00149 | DBMET00149 | |
| 0.076 | 0.197 | 0.162 | Anticoagulant | 0.162 0.071 DBMET00150 | DBMET00150 | |
| 0.008 | 0.13 | 0.036 | Sodium/glucose cotransporter 2 inhibitor | 0.036 0.009 DBMET00150 | DBMET00150 | |
| 0.073 | 0.201 | 0.463 | Angiogenesis stimulant | 0.463 0.014 DBMET00150 | DBMET00150 | |
| 0.13 | 0.26 | 0.313 | Peptidyltransferase inhibitor | 0.313 0.02 DBMET00150 | DBMET00150 | |
| 0.049 | 0.179 | 0.089 | DNA intercalator | 0.089 0.087 DBMET00150 | DBMET00150 | |
| 0.016 | 0.147 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET00150 | DBMET00150 | |
| 0.072 | 0.206 | 0.138 | Protein-tyrosine phosphatase inhibitor | 0.138 0.092 DBMET00149 | DBMET00149 | |
| 0.052 | 0.186 | 0.097 | NADH dehydrogenase inhibitor | 0.097 0.047 DBMET00150 | DBMET00150 | |
| 0.061 | 0.196 | 0.234 | Lipid peroxidase inhibitor | 0.139 0.076 DBMET00148 0.108 0.106 DBMET00149 0.234 0.03 DBMET00150 | DBMET00150 | |
| 0.038 | 0.192 | 0.056 | Lipocortins synthesis agonist | 0.056 0.045 DBMET00150 | DBMET00150 | |
| 0.087 | 0.25 | 0.133 | Interferon gamma antagonist | 0.133 0.104 DBMET00150 | DBMET00150 | |
| 0.025 | 0.196 | 0.054 | Heparanase inhibitor | 0.054 0.034 DBMET00150 | DBMET00150 | |
| 0.043 | 0.215 | 0.131 | UDP-glucose 4-epimerase inhibitor | 0.131 0.036 DBMET00150 | DBMET00150 | |
| 0.083 | 0.258 | 0.159 | Antiamyloidogenic | 0.159 0.136 DBMET00150 | DBMET00150 | |
| 0.072 | 0.252 | 0.15 | Hexokinase inhibitor | 0.15 0.078 DBMET00150 | DBMET00150 | |
| 0.075 | 0.256 | 0.29 | Platelet adhesion inhibitor | 0.29 0.037 DBMET00150 | DBMET00150 | |
| 0.037 | 0.223 | 0.096 | Expectorant | 0.096 0.073 DBMET00150 | DBMET00150 | |
| 0.118 | 0.306 | 0.43 | Immunosuppressant | 0.43 0.053 DBMET00150 | DBMET00150 | |
| 0.073 | 0.268 | 0.294 | Hepatoprotectant | 0.294 0.031 DBMET00150 | DBMET00150 | |
| 0.026 | 0.222 | 0.072 | Topoisomerase II alpha inhibitor | 0.072 0.06 DBMET00150 | DBMET00150 | |
| 0.075 | 0.271 | 0.147 | DNA repair enzyme inhibitor | 0.147 0.034 DBMET00150 | DBMET00150 | |
| 0.01 | 0.215 | 0.026 | Phosphodiesterase 6A inhibitor | 0.026 0.011 DBMET00149 | DBMET00149 | |
| 0.044 | 0.258 | 0.103 | DNA polymerase I inhibitor | 0.103 0.083 DBMET00150 | DBMET00150 | |
| 0.069 | 0.284 | 0.265 | Nitric oxide antagonist | 0.265 0.048 DBMET00150 | DBMET00150 | |
| 0.104 | 0.322 | 0.222 | Cholesterol antagonist | 0.222 0.146 DBMET00150 | DBMET00150 | |
| 0.041 | 0.261 | 0.098 | AMP-activated protein kinase stimulant | 0.098 0.074 DBMET00150 | DBMET00150 | |
| 0.033 | 0.267 | 0.114 | Topoisomerase II inhibitor | 0.114 0.073 DBMET00150 | DBMET00150 | |
| 0.016 | 0.251 | 0.054 | Antibiotic Aminoglycoside-like | 0.054 0.011 DBMET00150 | DBMET00150 | |
| 0.071 | 0.329 | 0.26 | Vasodilator | 0.26 0.064 DBMET00150 | DBMET00150 | |
| 0.029 | 0.293 | 0.066 | Adenine nucleotide translocase inhibitor | 0.066 0.02 DBMET00150 | DBMET00150 | |
| 0.109 | 0.393 | 0.33 | Apoptosis antagonist | 0.33 0.066 DBMET00150 | DBMET00150 | |
| 0.052 | 0.345 | 0.359 | Immunostimulant | 0.359 0.062 DBMET00150 | DBMET00150 | |
| 0.02 | 0.324 | 0.051 | Factor IXa inhibitor | 0.051 0.035 DBMET00150 | DBMET00150 | |
| 0.026 | 0.333 | 0.102 | Alkylator | 0.102 0.086 DBMET00150 | DBMET00150 | |
| 0.039 | 0.388 | 0.095 | Transcription factor NF kappa B stimulant | 0.095 0.044 DBMET00150 | DBMET00150 | |
| 0.08 | 0.435 | 0.315 | Immunomodulator | 0.315 0.074 DBMET00150 | DBMET00150 | |
| 0.036 | 0.409 | 0.1 | Cell adhesion inhibitor | 0.1 0.09 DBMET00150 | DBMET00150 | |
| 0.006 | 0.386 | 0.024 | Protein 30S ribosomal subunit inhibitor | 0.024 0.016 DBMET00150 | DBMET00150 | |
| 0.062 | 0.447 | 0.196 | Angiogenesis inhibitor | 0.196 0.174 DBMET00150 | DBMET00150 | |
| 0.024 | 0.427 | 0.107 | Beta glucuronidase inhibitor | 0.107 0.06 DBMET00150 | DBMET00150 | |
| 0.029 | 0.486 | 0.143 | Toll-Like receptor 4 antagonist | 0.143 0.025 DBMET00150 | DBMET00150 | |
| 0.056 | 0.531 | 0.534 | Antibacterial | 0.534 0.032 DBMET00150 | DBMET00150 | |
| 0.034 | 0.675 | 0.121 | NOS3 expression enhancer | 0.121 0.114 DBMET00150 | DBMET00150 | |
| 0.013 | 0.759 | 0.222 | Tumour necrosis factor alpha release inhibitor | 0.222 0.091 DBMET00150 | DBMET00150 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |